Sensitization to clavulanic acid in Augmentin.
Kamphof
W G
WG
Department of Occupational Dermatology, VU University Medical Center, Amsterdam, the Netherlands.
Rustemeyer
T
T
Bruynzeel
D P
DP
D019980:Amoxicillin-Potassium Clavulanate Combination / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D019818:Clavulanic Acid / Q000009:adverse effects*; D003550:Cystic Fibrosis / Q000150:complications; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology; D005260:Female; D006801:Humans; D007223:Infant; D007428:Intradermal Tests; D010328:Patch Tests; D011014:Pneumonia / Q000150:complications / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D019818:Clavulanic Acid; D019980:Amoxicillin-Potassium Clavulanate Combination